Earnings Feed
Start Free
Home/Insiders/Kelly James Patrick
KJ
SEC Insider//CIK 0001506314

Kelly James Patrick

CIK 00015063143 companiesGAITHERSBURG, MD
SEC Profile

Transactions

50

Companies

3

Filings

7

CIK

0001506314

Recent Transactions

50 trades
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2026-03-07$9.98/sh−5,904→ 130,599 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2026-03-07−12,223→ 0 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2026-03-07+12,223→ 136,503 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2026-03-03−43,167→ 86,333 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2026-03-03+43,167→ 145,130 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2026-03-03$9.49/sh−20,850→ 124,280 total
  • Award
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2026-03-02+129,500→ 129,500 total
  • Award
    NOVAVAX INC$NVAX

    Non-statutory Stock Option NQ

    2026-03-02$9.09/sh+194,000→ 194,000 total
  • Award
    NOVAVAX INC$NVAX

    Non-statutory Stock Option NQ

    2026-03-02+194,000→ 194,000 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2026-03-01$10.14/sh−28,366→ 101,963 total
  • Disposition to Issuer
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2026-03-01−58,666→ 58,666 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2026-03-01+58,666→ 130,299 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2025-03-07+12,223→ 75,155 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2025-03-07$8.34/sh−5,904→ 69,251 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2025-03-07−12,223→ 12,223 total
  • Award
    NOVAVAX INC$NVAX

    2025 Restricted Stock Units RSU

    2025-03-03+129,500→ 129,500 total
  • Award
    NOVAVAX INC$NVAX

    2025 Non-statutory Stock Option NQ

    2025-03-03$7.87/sh+194,500→ 194,500 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2025-03-01−58,667→ 117,333 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2025-03-01+58,667→ 91,269 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2025-03-01$8.33/sh−28,337→ 62,932 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2024-12-31+35,000→ 49,508 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2024-12-31−35,000→ 0 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2024-12-31$8.04/sh−16,906→ 32,602 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2024-08-16−2,367→ 0 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2024-08-16$12.96/sh−1,223→ 14,429 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2024-08-16$12.96/sh+2,367→ 15,652 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2024-03-10−4,608→ 4,608 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2024-03-10+4,608→ 15,511 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2024-03-10$5.45/sh−2,226→ 13,285 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2024-03-07−12,224→ 24,446 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2024-03-07+12,224→ 16,808 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2024-03-07$5.61/sh−5,905→ 10,903 total
  • Award
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2024-03-01+176,000→ 176,000 total
  • Award
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2023-09-12−35,000→ 35,000 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2023-08-16+2,366→ 5,727 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2023-08-16$7.13/sh−1,143→ 4,584 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2023-08-16−2,366→ 2,367 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2023-03-10$6.52/sh+4,609→ 5,832 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2023-03-10−4,609→ 9,216 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2023-03-10$6.52/sh−2,471→ 3,361 total
  • Award
    NOVAVAX INC$NVAX

    Stock Option (Right to Buy)

    2023-03-07+42,350→ 42,350 total
  • Award
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2023-03-07+36,670→ 36,670 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2022-08-16−2,367→ 4,733 total
  • Tax Payment
    NOVAVAX INC$NVAX

    Common Stock

    2022-08-16$42.88/sh−1,144→ 1,223 total
  • Exercise/Conversion
    NOVAVAX INC$NVAX

    Common Stock

    2022-08-16+2,367→ 2,367 total
  • Award
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2022-03-10+13,825→ 13,825 total
  • Award
    NOVAVAX INC$NVAX

    Stock Option (Right to Buy)

    2022-03-10+20,737→ 20,737 total
  • Award
    NOVAVAX INC$NVAX

    Stock Option (Right to Buy)

    2021-08-16+14,200→ 14,200 total
  • Award
    NOVAVAX INC$NVAX

    Restricted Stock Units

    2021-08-16+7,100→ 7,100 total
  • Award
    SUPERNUS PHARMACEUTICALS, INC.$SUPN

    Employee Stock Option (Right to Buy)

    2021-02-19+15,000→ 15,000 total

Companies

3

Recent Filings

7

Address

21 FIRSTFIELD ROAD

GAITHERSBURG, MD, 20878

View on SEC.gov